Hello. Would it be possible to get more details about what your advantages are compared to potential competitors such as Demetrix and Cronos group? It seems these other companies also use yeast. What are you doing differently and why do you think it would give you an edge over...

The information about each competitor is limited and our judgment is coming from publicly available information. The point below could be wrong due to limited information to the current stage of R&D by competitors. Demetrix: 1. they are using a baker's yeast (Saccharomyces cerevisiae) for production which has significantly fewer precursors (Acetyl-CoA). 2. They are using gene csPT4 for the production of CBGA. This gene is not specific. It is producing not only CBGA but also sesqui-CBGA. 3...

Does your company operate in a cGMP or better manufacturing facility? What is the size is the facility you are using for manufacturing, labs, R&D etc?

we are not in the production stage yet. We don't have cGMP facility yet. We are using 8,000 sqft facility in Fremont, CA. Once we begin large scale production in early 2022 it will be in a GMP certified facility

Where can I find your SEC filings? Financial Information?

We have just filed with the SEC. The financial info will be available in the next couple of days. I will update you once it's public.

Can't find it anywhere , what's the per share cost?

The share price is $4.50. We are hoping and planning on going public next year at a much higher price. 10-15 dollars but there are no guarantees that we will be able to do so. We are very confident though

Hi team, I'm interested in investing $10k in this project but could you elaborate a bit on what the investors get in return for their investment? Is it a convertible note or what tool? thanks!

The share price is $4.50. We are hoping and planning on going public next year at a much higher price. 10-15 dollars but there are no guarantees that we will be able to do so. We are very confident though.

Biomedican inc Updates, Team, and Funding Progress | Wefunder, Home of the Community Round

1

Medical-use, non-GMO cannabinoids for 70-90% less than current, wholesale prices

2

Costs less than $1/gram per cannabinoid using 90% less resources; 4 patents pending

3

70+ press mentions; Forbes, Bloomberg, Nasdaq, Reuters, Maxim, Rolling Stones

4

Partnered with Institute of Genetics Moscow, Demark Technical University, Imperial College UK

5

CBG reduces pain, inflammation; treats Glaucoma, Huntington's disease, IDB

6

THCV helps with diabetes, inflammation, neuroprotection, & bone growth

7

One of the fastest growing markets in the world; expected to reach $25B in 2025

Biomedican inc

Producing medical-grade cannabis more efficiently

$220,467

Highlights

Team

Memo

Biomedican inc

Quick facts

Team profiles

Featured investor profiles

$220,467

Highlights

Related company links

Team

Memo